about
Year in review 2010: Critical Care--Neurocritical careThe importance of early brain injury after subarachnoid hemorrhage[Aneurysmal subarachnoid hemorrhage].Correlation of transcranial color Doppler to n20 somatosensory evoked potential detects ischemic penumbra in subarachnoid hemorrhage.Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage.Toward Understanding Non-coding RNA Roles in Intracranial Aneurysms and Subarachnoid HemorrhageRuptured intracranial mycotic aneurysm in infective endocarditis: a natural historyNorepinephrine as a potential aggravator of symptomatic cerebral vasospasm: two cases and argument for milrinone therapy.Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage.A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].Polyuria and cerebral vasospasm after aneurysmal subarachnoid hemorrhage.Benefits of early aneurysm surgery: Southern Iran experienceImpact of admission month on outcomes in spontaneous subarachnoid hemorrhage: evidence against the march effect.Is asymptomatic vasospasm associated with poor outcome in subarachnoid hemorrhage?PPARβ/δ, a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats.Neurosurgical intensive care unit--essential for good outcomes in neurosurgery?Early management of stroke patients in the emergency department.Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol.New therapeutic approaches to subarachnoid hemorrhage.Is the circulating plasma volume sufficiently maintained? Fluid management of an aneurysmal subarachnoid hemorrhage in the acute phase.Rescue therapy for refractory vasospasm after subarachnoid hemorrhage.Regional brain monitoring in the neurocritical care unit.Beta Blockade and Clinical Outcomes in Aneurysmal Subarachnoid HemorrhageBeyond delayed cerebral vasospasm: infarct patterns in patients with subarachnoid hemorrhage.Can S100B Predict Cerebral Vasospasms in Patients Suffering from Subarachnoid Hemorrhage?Sulforaphane enhances the activity of the Nrf2-ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells.Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects.Microalbuminuria, macroalbuminuria and uncontrolled blood pressure among diagnosed hypertensive patients: the aspect of racial disparity in the NHANES study.Potential dual role of nuclear factor-kappa B in experimental subarachnoid hemorrhage-induced early brain injury in rabbits.[Volume replacement in intensive care medicine].Intracranial aneurysm with concomitant rupture of an undiagnosed visceral artery aneurysm.A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.Racial Disparity in the Associations of Microalbuminuria and Macroalbuminuria with Odds of Hypertension: Results from the NHANES Study in the United StatesMorphology of Middle Cerebral Artery Aneurysms: Impact on Surgical Strategy and on Postoperative Outcome
P2860
Q27016627-39F043BB-C8C7-4222-AC82-43B436B955EAQ27028040-B8B7EF4A-CBB4-4729-8792-F60D81821E1AQ30317996-1A993F6F-8C0D-49B8-AC07-5EBED76AF270Q30475178-FF7193CA-4BDF-4243-90BB-CE51411CB699Q30492969-6C5F741A-C89E-4BBA-BF9F-1DC4051CA079Q33917323-2A3B33FA-CFEE-4C33-861D-AC7E76DE7A27Q34159391-CDF84A2E-5EBE-4D34-895E-B4941BFB7A09Q34562391-78104CC1-CED4-4CD5-A174-6558EC093FF0Q35622343-6D5F090F-8C9E-4A6B-913B-C294021C7172Q35703367-57967876-CE6A-4E57-938C-0AB372689B52Q35805215-A4DBD599-8887-4CC4-B7F3-EB965363C0CDQ36551691-458A986B-B8FA-4754-A730-DB3F4ADF4C23Q36992984-10BDEEC6-6931-4CD7-A576-F1BB1AC7F4A4Q37052656-390651CD-485B-4B59-98B3-466D2F084770Q37714847-D084985E-7331-4F15-9704-08EBD71B2C04Q37850724-0D1AA7F8-551A-4CF0-AD1D-99ACC59F075BQ37895390-DD70BB7D-ED33-4CAA-B809-191674DF044CQ37900528-B969F705-06AF-42E2-8B62-410170B1DEA3Q38004985-BB8352A5-0FE0-4F47-8932-7344A29BD8E4Q38005212-D48CFD75-FC6F-4F68-AC77-CD8F8E9A269EQ38044546-43409FBD-9019-4BC6-B3CD-057E8996B35FQ38287055-B5643357-0521-45A0-9EF3-A84C10025A7CQ38400123-E48FE340-CF40-49EC-BFC7-B04E3D8B1BA7Q39143613-5F222694-9B41-493E-9559-BA096F3290DEQ40064869-485CD361-F52F-4762-9089-8954959AA201Q42137303-FB932AFD-92C9-42B7-906F-900585B6A82DQ44766943-A05E8B1A-BC73-46F7-84A2-63C5E9C5B33CQ45370559-44A9D70B-D0F8-48C5-8B7E-14CDDA0AFEDFQ46210665-E31EEF55-D642-4109-A5C8-9CD479F75AEBQ48467024-47EFC3BE-5783-4E58-94C2-07A1EE9A6E16Q50162593-2DA90E10-D15C-42C7-ABB4-B61594FEB684Q50529022-EB27D122-8314-4631-8434-6F12C81F38ADQ55019304-1C90689F-D258-4B5F-BC21-49CF8448FCA8Q58995274-F61CCF69-8CC9-422A-990A-2508485231ECQ58999775-81B3E243-A184-4820-A451-C52E932D4CDE
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Management of aneurysmal subarachnoid hemorrhage.
@ast
Management of aneurysmal subarachnoid hemorrhage.
@en
type
label
Management of aneurysmal subarachnoid hemorrhage.
@ast
Management of aneurysmal subarachnoid hemorrhage.
@en
prefLabel
Management of aneurysmal subarachnoid hemorrhage.
@ast
Management of aneurysmal subarachnoid hemorrhage.
@en
P2860
P1476
Management of aneurysmal subarachnoid hemorrhage
@en
P2093
Michael N Diringer
P2860
P304
P356
10.1097/CCM.0B013E318195865A
P407
P577
2009-02-01T00:00:00Z